Luca Sorvillo

Via L. De Crecchio 7
Naples, 80138, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 8 publications

Inorganic Phosphate Prevents Erk1/2 and Stat3 Activation and Improves Sensitivity to Doxorubicin of MDA-MB-231 Breast Cancer Cells.

Inorganic Phosphate Prevents Erk1/2 and Stat3 Activation and Improves Sensitivity to Doxorubicin of MDA-MB-231 Breast Cancer Cells.

Journal: Molecules (Basel, Switzerland)

Published: July 07, 2015

Inorganic Phosphate as a Novel Signaling Molecule with Antiproliferative Action in MDA-MB-231 Breast Cancer Cells.

Inorganic Phosphate as a Novel Signaling Molecule with Antiproliferative Action in MDA-MB-231 Breast Cancer Cells.

Journal: BioResearch open access

Published: March 22, 2013

cAMP Elevation Down-Regulates β3 Integrin and Focal Adhesion Kinase and Inhibits Leptin-Induced Migration of MDA-MB-231 Breast Cancer Cells.

cAMP Elevation Down-Regulates β3 Integrin and Focal Adhesion Kinase and Inhibits Leptin-Induced Migration of MDA-MB-231 Breast Cancer Cells.

Journal: BioResearch open access

Published: March 22, 2013

Integrating leptin and cAMP signalling pathways in triple-negative breast cancer cells.

Integrating leptin and cAMP signalling pathways in triple-negative breast cancer cells.

Journal: Frontiers in bioscience (Landmark edition)

Published: January 02, 2013

Inorganic phosphate as a signaling molecule: a potential strategy in osteosarcoma treatment.

Inorganic phosphate as a signaling molecule: a potential strategy in osteosarcoma treatment.

Journal: Current pharmaceutical design

Published: December 26, 2012

Synergistic cytotoxic effects of inorganic phosphate and chemotherapeutic drugs on human osteosarcoma cells.

Synergistic cytotoxic effects of inorganic phosphate and chemotherapeutic drugs on human osteosarcoma cells.

Journal: Oncology reports

Published: November 16, 2012

[Retracted] Synergistic cytotoxic effects of inorganic phosphate and chemotherapeutic drugs on human osteosarcoma cells.

[Retracted] Synergistic cytotoxic effects of inorganic phosphate and chemotherapeutic drugs on human osteosarcoma cells.

Journal: Oncology reports

Published: November 16, 2012

Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway.

Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway.

Journal: Journal of cellular physiology

Published: June 08, 2012

Showing 1-8 of 8

Last Updated: 09/26/2026